Advertisement
Research Article

Melioidosis Vaccines: A Systematic Review and Appraisal of the Potential to Exploit Biodefense Vaccines for Public Health Purposes

  • Sharon J. Peacock equal contributor,

    equal contributor Contributed equally to this work with: Sharon J. Peacock, Direk Limmathurotsakul

    Affiliations: Department of Microbiology and Immunology, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand, Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand, Department of Medicine, Cambridge University, Addenbrooke's Hospital, Cambridge, United Kingdom

    X
  • Direk Limmathurotsakul equal contributor mail,

    equal contributor Contributed equally to this work with: Sharon J. Peacock, Direk Limmathurotsakul

    direk@tropmedres.ac

    Affiliations: Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand, Department of Tropical Hygiene, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand

    X
  • Yoel Lubell,

    Affiliation: Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand

    X
  • Gavin C. K. W. Koh,

    Affiliations: Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand, Department of Medicine, Cambridge University, Addenbrooke's Hospital, Cambridge, United Kingdom

    X
  • Lisa J. White,

    Affiliation: Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand

    X
  • Nicholas P. J. Day,

    Affiliations: Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand, Nuffield Department of Clinical Medicine, Centre for Clinical Vaccinology and Tropical Medicine, University of Oxford, Churchill Hospital, Oxford, United Kingdom

    X
  • Richard W. Titball

    Affiliation: College of Life and Environmental Sciences, University of Exeter, Exeter, United Kingdom

    X
  • Published: January 31, 2012
  • DOI: 10.1371/journal.pntd.0001488

Reader Comments (1)

Post a new comment on this article

Error in Table S1

Posted by plosntds_team on 04 Mar 2013 at 17:40 GMT

Table S1 contains two items that require correction. The OMV vaccine given subcutaneously is listed as providing 0% protection against challenge; in fact, it provided 60% protection. Additionally, the challenge information should indicate 1000 CFU by aerosol instead of 5000 CFU intranasally.

Please view the correct Table S1 here: http://www.plosntds.org/c...

No competing interests declared.